Keywords: supergen, gets, patent, extending, extra, technology, taxol

SuperGen Gets Patent Extending Extra Technology To Taxol

Article | 25 June 1998

SuperGen has received a patent allowance to expand coverage of itsExtra drug technology to encompass Bristol-Myers Squibb's Taxol (paclitaxel) and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Go to company listing

Related Drugs

Paclitaxel

Taxol

Go to drug listing